Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) ...

Both drugs work by reducing the brain amyloid levels in patients in the early stages of Alzheimer’s, and act to slow the disease. Still, they don’t stop or reverse it, while both treatments ...

Diet, exercise, brain games, even using your non-dominant hand can help prevent the onset of Alzheimer's disease.

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Understanding dementia and Alzheimer’s disease is essential for maintaining a proactive approach to our well-being.

6, 2024 — Researchers have unraveled how immune cells called microglia can transform and drive harmful processes like neuroinflammation in Alzheimer's disease. The study also integrates drug ...

A report questions the FDA's accelerated approval process citing Sarepta and Biogen therapies as examples. Read more here.